Atlas Trials

The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans

Clinical trial NCT01943305 · COMPLETED

Trial details

NCT number
NCT01943305
Sponsor
Singapore General Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Yellow FeverEncephalitis, Japanese
Start date
2013-10-01
Primary completion
2015-06-01
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.